MDDAX | VIVIX | MDDAX / VIVIX | |
Total Expense Ratio | 1.14 | 0.04 | 2,850% |
Annual Report Gross Expense Ratio | 1.14 | 0.04 | 2,850% |
Fund Existence | 21 years | 27 years | - |
Gain YTD | 8.682 | 6.533 | 133% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 330M | 196B | 0% |
Annual Yield % from dividends | 1.36 | 2.19 | 62% |
Returns for 1 year | -18.51 | 7.91 | -234% |
Returns for 3 years | -14.16 | 25.93 | -55% |
Returns for 5 years | 9.92 | 68.54 | 14% |
Returns for 10 years | -19.06 | 114.61 | -17% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
COSZX | 14.16 | 0.08 | +0.57% |
Columbia Overseas Value Inst | |||
MSQLX | 11.52 | 0.02 | +0.17% |
Morgan Stanley Inst International Eq L | |||
HIMDX | 23.94 | -0.01 | -0.04% |
Hennessy Cornerstone Mid Cap 30 Instl | |||
VFINX | 596.00 | -1.60 | -0.27% |
Vanguard 500 Index Investor | |||
NESIX | 19.54 | -0.16 | -0.81% |
Needham Small Cap Growth Institutional |